section hero-home hero-section
hero-container container
hero image
mobile hero image
hero content
In hATTR amyloidosis...
DISEASE PROGRESSION UNRAVELS THEIR LIVES
Learn to recognize and diagnose hATTR amyloidosis.
The progression of hereditary transthyretin-mediated (hATTR) amyloidosis can pull apart your patients’ futures.1 Identifying the disease early may help patients hold on to their physical
function, independence, and well-being.2-5
section section-boxes mt-20 mb-5
boxes-container container
A multisystem, rapidly progressive disease
The multisystem, rapidly progressive nature of the disease leads to disability and premature death.1,6
One option for genetic testing, which can help confirm a diagnosis of hATTR amyloidosis7,8
Physician directory
Find physicians experienced in managing hATTR amyloidosis who are near your patients.
section section-References grey-bg
References-container container
References
References:
- Coutinho P, Martins da Silva A, Lopes Lima JL, et al. Excerpta Medica. 1980:88-98.
- Conceição I, González-Duarte A, Obici L, et al. J Peripher Nerv Syst. 2016;21(1):5-9.
- Berk J, Lin H, Agarwal S, et al. Poster presented at International Symposium on Amyloidosis; March 26-29, 2018; Kumamoto, Japan.
- Stewart M, Shaffer S, Murphy B, et al. Neurol Ther. 2018;7:349-364.
- Coelho T, Vinik A, Vinik EJ, et al. Muscle Nerve. 2017;55:323-332.
- Ando Y, Coelho T, Berk JL, et al. Orphanet J Rare Dis. 2013;8:31.
- Maurer MS, Elliott P, Comenzo R, et al. Circulation. 2017;135(14):1357-1377.
- Adams D, Suhr OB, Hund E, et al. Curr Opin Neurol. 2016;29(suppl 1):S14-S26.